These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 39075379)

  • 1. Emergency department utilization before and during the COVID-19 pandemic among individuals with sickle cell disease.
    Attell BK; Plaxco AP; Zhou M; Valle J; Reeves SL; Patel PN; Latta K; Smeltzer MP; Snyder AB
    BMC Emerg Med; 2024 Jul; 24(1):134. PubMed ID: 39075379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID-19 pandemic: A multicentre cohort study.
    Rech JS; Cohen A; Bartolucci P; Santin A; Chantalat Auger C; Affo L; Le Jeune S; Arlet JB; Boëlle PY; Steichen O
    Br J Haematol; 2024 Aug; 205(2):463-472. PubMed ID: 38960400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Patterns of Telehealth Use Among People with Sickle Cell Disease Enrolled in Medicaid During the Start of the COVID-19 Pandemic.
    Reeves SL; Plegue M; Patel PN; Paulukonis ST; Horiuchi SS; Zhou M; Attell BK; Pace BS; Snyder AB; Plaxco AP; Mukhopadhyay A; Smeltzer MP; Ellimoottil CS; Hulihan M
    Telemed J E Health; 2024 Jun; 30(7):e1971-e1979. PubMed ID: 38603584
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the COVID-19 Pandemic on Health Care Utilization in a Large Integrated Health Care System: Retrospective Cohort Study.
    Xu S; Glenn S; Sy L; Qian L; Hong V; Ryan DS; Jacobsen S
    J Med Internet Res; 2021 Apr; 23(4):e26558. PubMed ID: 33882020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergency department utilization by Californians with sickle cell disease, 2005-2014.
    Paulukonis ST; Feuchtbaum LB; Coates TD; Neumayr LD; Treadwell MJ; Vichinsky EP; Hulihan MM
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 28000344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell disease in California: sociodemographic predictors of emergency department utilization.
    Wolfson JA; Schrager SM; Khanna R; Coates TD; Kipke MD
    Pediatr Blood Cancer; 2012 Jan; 58(1):66-73. PubMed ID: 21360655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle-cell disease in California: a population-based description of emergency department utilization.
    Wolfson JA; Schrager SM; Coates TD; Kipke MD
    Pediatr Blood Cancer; 2011 Mar; 56(3):413-9. PubMed ID: 21225920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency department 30-Day emergency department revisits among people with sickle cell disease: Variations in characteristics.
    Rushing M; Horiuchi S; Zhou M; Kavanagh PL; Reeves SL; Snyder A; Paulukonis S
    Pediatr Blood Cancer; 2024 Oct; 71(10):e31188. PubMed ID: 39010280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency Department Utilization and Patient Outcomes During the COVID-19 Pandemic in America.
    Gutovitz S; Pangia J; Finer A; Rymer K; Johnson D
    J Emerg Med; 2021 Jun; 60(6):798-806. PubMed ID: 33581990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the COVID-19 pandemic on emergency department visits for serious cardiovascular conditions.
    Pines JM; Zocchi MS; Black BS; Celedon P; Carlson JN; Moghtaderi A; Venkat A;
    Am J Emerg Med; 2021 Sep; 47():42-51. PubMed ID: 33770713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency department utilization for sickle cell disease in St. Vincent and the Grenadines.
    Williams SA; Henson S; Trimmingham S; Newman J; Kanter J
    Pan Afr Med J; 2021; 38():100. PubMed ID: 33889266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease.
    Kayle M; Valle J; Paulukonis S; Holl JL; Tanabe P; French DD; Garg R; Liem RI; Badawy SM; Treadwell MJ
    Pediatr Blood Cancer; 2020 May; 67(5):e28152. PubMed ID: 32147964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the COVID-19 pandemic on emergency department utilization patterns in South Korea: A retrospective observational study.
    Chang H; Kang MW; Paek SH
    Medicine (Baltimore); 2022 Feb; 101(8):e29009. PubMed ID: 35212313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 pandemic-associated changes in overall emergency department visits by age group, race, and ethnicity - United States, January 2019-April 2022.
    Smith AR; DeVies J; Carey K; Sheppard M; Radhakrishnan L; Njai R; Ajani UA; Soetebier K; Hartnett K; Adjemian J
    Am J Emerg Med; 2023 Jul; 69():121-126. PubMed ID: 37087809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency Department Visits for Nonfatal Opioid Overdose During the COVID-19 Pandemic Across Six US Health Care Systems.
    Soares WE; Melnick ER; Nath B; D'Onofrio G; Paek H; Skains RM; Walter LA; Casey MF; Napoli A; Hoppe JA; Jeffery MM
    Ann Emerg Med; 2022 Feb; 79(2):158-167. PubMed ID: 34119326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing pediatric emergency department visits during the COVID-19 pandemic.
    Pines JM; Zocchi MS; Black BS; Carlson JN; Celedon P; Moghtaderi A; Venkat A;
    Am J Emerg Med; 2021 Mar; 41():201-204. PubMed ID: 33257144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency department visits and hospitalizations for pediatric vaso-occlusive pain events during the COVID-19 pandemic.
    Romanos-Sirakis E; Demissie S
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30213. PubMed ID: 36633226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: COVID-19 Pandemic-Associated Changes in Emergency Department Visits - United States, December 2020-January 2021.
    Adjemian J; Hartnett KP; Kite-Powell A; DeVies J; Azondekon R; Radhakrishnan L; van Santen KL; Rodgers L
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(15):552-556. PubMed ID: 33857069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute care utilization and rehospitalizations for sickle cell disease.
    Brousseau DC; Owens PL; Mosso AL; Panepinto JA; Steiner CA
    JAMA; 2010 Apr; 303(13):1288-94. PubMed ID: 20371788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute care utilization in pediatric sickle cell disease and sickle cell trait in the USA: prevalence, temporal trends, and cost.
    Peterson EE; Salemi JL; Dongarwar D; Salihu HM
    Eur J Pediatr; 2020 Nov; 179(11):1701-1710. PubMed ID: 32394268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.